Correlation Between Annexin Pharmaceuticals and Clinical Laserthermia

Can any of the company-specific risk be diversified away by investing in both Annexin Pharmaceuticals and Clinical Laserthermia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexin Pharmaceuticals and Clinical Laserthermia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Annexin Pharmaceuticals AB and Clinical Laserthermia Systems, you can compare the effects of market volatilities on Annexin Pharmaceuticals and Clinical Laserthermia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexin Pharmaceuticals with a short position of Clinical Laserthermia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexin Pharmaceuticals and Clinical Laserthermia.

Diversification Opportunities for Annexin Pharmaceuticals and Clinical Laserthermia

0.43

Correlation Coefficient

Annexin Pharmaceuticals  Clinical Laserthermia

Very weak diversification

The 3 months correlation between Annexin and Clinical is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Annexin Pharmaceuticals AB and Clinical Laserthermia Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clinical Laserthermia and Annexin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexin Pharmaceuticals AB are associated (or correlated) with Clinical Laserthermia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clinical Laserthermia has no effect on the direction of Annexin Pharmaceuticals i.e., Annexin Pharmaceuticals and Clinical Laserthermia go up and down completely randomly.

Pair Corralation between Annexin Pharmaceuticals and Clinical Laserthermia

Assuming the 90 days trading horizon Annexin Pharmaceuticals AB is expected to generate 0.65 times more return on investment than Clinical Laserthermia. However, Annexin Pharmaceuticals AB is 1.54 times less risky than Clinical Laserthermia. It trades about -0.02 of its potential returns per unit of risk. Clinical Laserthermia Systems is currently generating about -0.15 per unit of risk. If you would invest  50.00  in Annexin Pharmaceuticals AB on September 5, 2024 and sell it today you would lose (2.00) from holding Annexin Pharmaceuticals AB or give up 4.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Annexin Pharmaceuticals AB  vs.  Clinical Laserthermia Systems

Annexin Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Annexin Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Clinical Laserthermia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clinical Laserthermia Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Clinical Laserthermia is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Annexin Pharmaceuticals and Clinical Laserthermia

The main advantage of trading using opposite Annexin Pharmaceuticals and Clinical Laserthermia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexin Pharmaceuticals position performs unexpectedly, Clinical Laserthermia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinical Laserthermia will offset losses from the drop in Clinical Laserthermia's long position.

The idea behind Annexin Pharmaceuticals AB and Clinical Laserthermia Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.